Not only it inhibits enzymes essential to Plasmodium's survival in two key stages of its lifecycle in humans, but triclosan also performed well in tests against resistant parasites, an international study reveals. The efficiency of malaria treatment with mostly used drugs is undermined by resistant lineages and by the fact that patients present severe side effects in 10 percent of the cases.